Home › Funds › Pier Capital, LLC › DRTS

Pier Capital, LLC position in DRTS

ALPHA TAU MEDICAL LTD · Health Care

Pier Capital, LLC reported holding 730,208 shares of DRTS (ALPHA TAU MEDICAL LTD) in its Q3 2026 13F filing — a position valued at US$10.9M, representing 1.58% of its reported portfolio and ranking #11 among its reported holdings. Pier Capital, LLC has disclosed DRTS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)730.21K sh
Reported value held$10.89M
Portfolio Weight1.58%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Pier Capital, LLC's DRTS position evolved

Pier Capital, LLC first disclosed a stake in DRTS in Q2 2026 at 691,939 shares (US$8.7M). The position peaked in Q3 2026 at 730,208 shares, worth US$10.9M. Across 2 filings, Pier Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 730,208 shares valued at US$10.9M — an increase of 38,269 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 691.94K $8.70M New
Q3 2026 730.21K $10.89M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DRTS and 13F data

DRTS (ALPHA TAU MEDICAL LTD) is a Health Care company. 67 other funds we track also report a position in DRTS — the largest reported positions include Gem Investment Advisors, LLC (US$18.0M), Aquamarine Financial (Cayman) Ltd (US$9.1M), Daytona Street Capital LLC (US$1.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DRTS

All DRTS fund holders →

FAQ

How long has Pier Capital, LLC held DRTS?

Pier Capital, LLC has disclosed DRTS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Pier Capital, LLC's current position in DRTS?

As of Q3 2026, Pier Capital, LLC holds 730.21K shares of DRTS (ALPHA TAU MEDICAL LTD), valued at $10.89M, representing 1.58% of its reported portfolio and ranking #11.

Has Pier Capital, LLC been buying or selling DRTS?

In the latest 13F filing (Q3 2026), Pier Capital, LLC increased its position in DRTS. The position peaked in Q3 2026 at 730.21K shares.

Which other funds hold DRTS?

Other major institutional holders of DRTS include Gem Investment Advisors, LLC, Aquamarine Financial (Cayman) Ltd, Daytona Street Capital LLC, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.